According to research by Uribarri et al. the expression levels of APOA1, CO4A, CRP, GSTP1, and SAMP led to a diagnostic panel for lung cancer that was 95% sensitive and 81% specific. This evidence concerns the gene APOA1 and lung carcinoma.